These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33925423)

  • 1. SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population.
    Marcos S; Albiñana V; Recio-Poveda L; Tarazona B; Verde-González MP; Ojeda-Fernández L; Botella LM
    J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33925423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy.
    Suppressa P; Pagella F; Lenato GM; Gaetani E; Serio I; Masala MS; Spinozzi G; Lizzio R; Matti E; De Silvestri A; Passali GC; Aguglia M; Crocione C; Sabbà C
    Orphanet J Rare Dis; 2021 Sep; 16(1):378. PubMed ID: 34496900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study.
    Suppressa P; Maiorano E; Gaetani E; Matti E; Lenato GM; Serio I; Masala MS; Passali GC; Aguglia M; Crocione C; Lopalco PL; Caneschi F; Musella V; De Silvestri A; Gambini G; Spinozzi G; Sabbà C; Pagella F
    Intern Emerg Med; 2023 Jun; 18(4):1109-1118. PubMed ID: 37140873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab.
    Pagella F; Lizzio R; Ugolini S; Spinozzi G; Maiorano E; Suppressa P; Sabbà C; Matti E
    Orphanet J Rare Dis; 2020 Dec; 15(1):350. PubMed ID: 33339521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health and counseling intervention for hereditary hemorrhagic telangiectasia (HHT) during the COVID-19 pandemic: perspectives from Italy.
    Marano G; Gaetani E; Gasbarrini A; Janiri L; Sani G; Mazza M;
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10225-10227. PubMed ID: 33090433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis.
    Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S
    Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
    Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
    Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
    Conti P; Gallenga CE; Tetè G; Caraffa A; Ronconi G; Younes A; Toniato E; Ross R; Kritas SK
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):333-338. PubMed ID: 32228825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.
    Madas BG; Füri P; Farkas Á; Nagy A; Czitrovszky A; Balásházy I; Schay GG; Horváth A
    Sci Rep; 2020 Dec; 10(1):22430. PubMed ID: 33384436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
    Mezoh G; Crowther NJ
    Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
    Valencia I; Peiró C; Lorenzo Ó; Sánchez-Ferrer CF; Eckel J; Romacho T
    Front Pharmacol; 2020; 11():1161. PubMed ID: 32848769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericytes in Hereditary Hemorrhagic Telangiectasia.
    Galaris G; Thalgott JH; Lebrin FPG
    Adv Exp Med Biol; 2019; 1147():215-246. PubMed ID: 31147880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
    Brinjikji W; Iyer VN; Wood CP; Lanzino G
    J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.